VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis
Status:
Completed
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
Phase I study in patients with metastatic colorectal cancer with liver metastasis under
second or third line therapy to examine safety, efficacy, and immune biomarkers after
treatment with VXM01